Author:
Höhn Anne Kathrin,Brambs Christine E.,Hiller Grit Gesine Ruth,Forberger Mirjam,Freude Annekathrin,Krücken Irene,Horn Lars-Christian
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. AWMF (2025) Vorbereitung, S3-Leitlinie Diagnostik, Therapie und Nachsorge der Patientin mit Vulvakarzinom und seiner Vorstufen. Registernummer 032–059OL. Leitlinienprogramm Onkologie von AWMF, DKG und DKH. awmf.org. Zugegriffen: 24. Jan. 2024
2. Barlow EL, Lambie N, Donoghoe MW, Naing Z, Hacker NF (2020) The clinical relevance of p16 and p53 status in patients with squamous cell carcinoma of the vulva. J Oncol 2020:3739075. https://doi.org/10.1155/2020/3739075
3. Brambs CE, Horn L‑C, Mende M, Höckel M, Eckey C, Hiller GGR, Höhn AK (2022) Epithelial-mesenchymal transition (EMT) in vulvar cancer with and without inguinal lymph node involvement. J Cancer Res Clin Oncol 148(5):1183–1193. https://doi.org/10.1007/s00432-021-03715-2
4. Carreras-Dieguez N, Guerrero J, Rodrigo-Calvo MT, Ribera-Cortada I, Trias I, Jares P, Del López Campo R, Saco A, Munmany M, Marimon L, Ferrando M, Vega N, del Pino M, Torné A, Ordi J, Rakislova N (2021) Molecular landscape of vulvar squamous cell carcinoma. Int J Mol Sci. https://doi.org/10.3390/ijms22137069
5. Carreras-Dieguez N, Saco A, del Pino M, Marimon L, Del López Campo R, Manzotti C, Fusté P, Pumarola C, Torné A, Garcia A, Rakislova N (2023) Human papillomavirus and p53 status define three types of vulvar squamous cell carcinomas with distinct clinical, pathological, and prognostic features. Histopathology 83(1):17–30. https://doi.org/10.1111/his.14925